Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients

NCT03402256 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03402256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
March 22, 2013
Completion date
May 6, 2014
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic liver disease